Thank you very much for submitting your study characterizing Tfcp2l1 as critical pluripotency factor downstream of LIF for consideration to The EMBO Journal editorial office.
3. The 6136 genes expressed in ES cells and bound by Tfcp2l1 should be included as supplementary data.
In results section, it is not clear how it is concluded that "This widespread binding suggests that
Tfcp2l1 may be a rather general regulator..." Please clarify, move to discussion, or remove. Figure 3 has a typo: written as "3E", but should be "3H".
Legend in
6. Scale bars should be added to figures 3H and 4C.
7. Pim1 comes up several times in the results, but gets no mention in the discussion. Perhaps some comment is warranted.
8. Be good to comment about whether other pluripotency TF's bind at Tfcp2l1. 9. Please provide section headings in results section.
Referee #2:
In this manuscript, Graziano Martello and colleagues uncover Tcfp2l1 as a critical downstream target of LIF/Stat3 signalling pathway in mouse ES cells. Here, the authors take advantage of Stat3-/-ES cells, which retain their self-renewal and pluripotent abilities if maintained in the presence of Mek and Gsk3 (2i) inhibitors. Other conditions (serum+LIF and PD+LIF) in contrast severely compromise Stat3-/-ES cell self-renewal, as the cells fail to respond to LIF signal transduction. Combining RNA-Seq analysis in LIF-stimulated Stat3+/+ and Stat3-/-ES cells and Stat3 ChiP-Seq dataset, they identify and validate Tcfp2l1 as a primary LIF/Stat3 target. Accordingly, Tcfp2l1 forced expression can substitute for LIF/Stat3 in Stat3-/-ES cells and furthermore supports an undifferentiated ES cell state in non-permissive conditions. Conversely, conditional loss of Tcfp2l1 is detrimental to ES cells unless grown in 2i+LIF conditions. Interrogation of Tcfp2l1 ChiP-Seq dataset indicates that Tcfp2l1 might partly act 'outside' the core transcriptional network to sustain ES cell self-renewal, with many Tcfp2l1-bound target genes being expressed in 2i+LIF conditions. Beyond its role in maintaining the ES cell identity, Tcfp2l1 is also revealed as a potent mediator of EpiS cell reprogramming to naïve pluripotency. Overall, I believe that this manuscript would be a 1-The study indicates that Tcfp2l1 potentially functions in parallel to the core transcriptional network to sustain ES cell self-renewal but falls short in explaining how Tcfp2l1 operates in this context. Figure 3F -G suggests that Tcfp2l1 plays a role in ES cell survival in addition to restraining differentiation. Could the authors clarify whether Tcfp2l1 conditional deletion indeed leads to an increased incidence of apoptosis (potentially rescued in the presence of caspase inhibitors) and whether "surviving" colonies retain a positive AP-staining? Important clues might also come from detailed gene ontology analysis of Tcfp2l1-bound targets ( Figure 5E ) with a specific focus on Tcfp2l1-bound genes that are expressed in 2i+LIF conditions as compared to serum + LIF (Marks et al. 2012 ).
2-The authors report that Tcfp2l1 is homogeneously expressed in ES cells in contrast to Klf4 and many other pluripotency transcription factors ( Figure 3H ), suggesting that Tcfp2l1 "... may underlie the capacity of LIF to sustain self-renewal efficiently in serum when other factors are more restricted". This is an interesting observation that needs to be further explored, as this could provide additional insights into how Tcfp2l1 operates in ES cells. The authors should perhaps take advantage of the recently established Esrrb -/-ES cells (Martello et al. 2012) , as these cells were shown to strictly rely on LIF to accommodate the loss of Esrrb. Figure 6 , GOF18 EpiS cells are shown to convert to naïve pluripotency in the presence of 2i+ LIF but not 2i alone, and this correlates with an enhanced induction of Tcfp2l1. In contrast, 2i+ LIF (or 2i) is not sufficient to induce reprogramming of O4GIP-EpiS cells, which is however elicited by either the hyper-activation of endogenous Stat3 or Tcfp2l1 forced expression in the presence of 2i. Could the authors verify whether (or not) both GOF18 and O4GIP-EpiS cell lines express LIF receptor? Variability in EpiS cell reprogramming efficiency could also reflect the initial transcriptional status of Tcfp2l1 itself in Activin + Fgf conditions; repressed in O4GIP cells, but expressed either at low levels or within a subpopulation of GOF18 cells (to be assessed by western blotting and/or IF), yet further induced in response to 2i+LIF. Clarifying this point might further support the view that Tcfp2l1 expression closely delineates the transition between naÔve and primed pluripotency states, as previously suggested (Pelton et al., 2002) .
3-In

Minor concerns:
- Figure 1B and Figure 2D : please define RPKM in legend figure.
- Figure 3A : could the authors validate that all five PB-transgenes are expressed at similar levels (western blotting) prior to and after LIF removal? - Figure 3 : Data showing that Tcfp2l1-depleted ES cells are rescued in 2i + LIF need to be included in this manuscript.
- Figure 4 : Different panels use 2i+LIF instead of PD +LIF as control conditions to be compared with PD alone. This needs to be changed or appropriately justified.
-Figures 6C and 6I: Legend axes are missing. Note that data presentation in these panels does not allow direct comparisons in gene expression levels between O4GIP and GOF18 cells in Activin + Fgf conditions.
- Figure 6K : please include ES cells 2i + LIF control as in Figure 6G and comment on any potential difference in the extent to which the expression of ES cell-associated factors is regained in O4GIP and GOF18 cells upon Tcfp2l1 forced expression.
Referee #3:
The authors use a genome-wide approach and compared the transcriptiome of Stat3-null ESCs with available transcriptiome data to identify genes, whose expression could sustain self-renewal and pluripotency in the absence of LIF. They found a transcription factor, Tfcp2l1, which is necessary and sufficient to maintain pluripotency and self-renewal of ESCs and essential for the reprogramming of EpiSCs. The authors concluded Tfcp2l1 to be a major component of the LIF/Sat3 signaling pathway that is linked to the core transcription factors required for the maintenance of naive pluripotency. Overall the data are convincing and in accordance with the author's conclusions. However, there are minor comments to be addressed. 1) It is surprising that the authors did not found NANOG in their screening. NANOG shown to support LIF-independent self-renewal of mouse ESCs (Niwa et al., 2009. Nature 460: 118-122) . Additionally, the authors have previously shown that the pluripotent factor Esrrb was also necessary and sufficient to sustain self-renewal and pluripotency of ESCs downstream Gsk3 inhibition (Martello et al., 2012. Cell Stem Cell 11: 491-504 Figures 2E and 2G, the authors found Gbx2 expression to be responsive yet independent of LIF and suggested the potential of additional mechanisms associated to Gbx2 expression in ESCs. These data are somewhat divergent from recent findings showing Gbx2 as a LIF/Stat3 downstream target, which upon forced expression is sufficient to maintain self-renewal of ESCs in the absence of LIF. (Tai and Ying, 2013 . J. Cell Sci. 126: 1093 -1098 . Furthermore, ectopic expression of Gbx2 enhanced reprogramming of MEFs into iPS and was sufficient to reprogram EpiSCs to pluripotent state ESCs (Tai and Ying, 2013 . J. Cell Sci. 126: 1093 -1098 . Again, how is Tfcp2l1 function integrated with that of Gbx2? 3) Regarding Figure 4E , it would be best to include a graphical representation to better depict the result in the colony formation assay. 4) The heatmap on Figure 6C shows the expression of Tfcp2l1 along with Gbx2 and Socs3 to be significantly increased after 48 hrs in 2i media under activated Stat3 conditions. Interestingly, the role of Socs3 was not evaluated by siRNA-targeting in the reprogramming assay on Figure 6D . Additionally, the effect of knocking down Pim1 does not seem to be statistically significantly different (by looking at the error bars) from the siRNA-mediated down regulation of Tfcp2l1. 5) A schematic representation or a model figure by incorporating the role of Tfcp2l1 into what is already known about the maintenance of pluripotency and self-renewal could greatly benefit the understanding of the data. 6) Consider changing the title to: a) Identification of a new Pluripotency Promoting Factor Downstream of Leukaemia Inhibitory Factor; or b) Identification of Tfcp2l1 as a novel Pluripotency Promoting Factor Downstream of Leukaemia Inhibitory Factor 1. The title is a bit grandiose in the stating "the critical pluripotency factor." At least say "a critical pluripotency factor." Perhaps even better to simply state that Tfcp2l1 is the factor. We have removed Figure 5F and the text related to it (see point 4). Table S5 .
The point of this study was to identify the essential mediator(s) of the ES cell self-renewal response to LIF. The results clearly demonstrate that
The list of genes bound by Tfcp2l1 is now in
4. In results section, it is not clear how it is concluded that "This widespread binding suggests that Tfcp2l1 may be a rather general regulator..." Please clarify, move to discussion, or remove. Figure 3 has a typo: written as "3E", but should be "3H".
We have removed this comment
Legend in
Corrected.
6. Scale bars should be added to figures 3H and 4C. Done 7. Pim1 comes up several times in the results, but gets no mention in the discussion. Perhaps some comment is warranted.
We have added mention of Pim1 in the Discussion.
8. Be good to comment about whether other pluripotency TF's bind at Tfcp2l1.
This is a good point and is now included.
9. Please provide section headings in results section.
Done
In this manuscript, Graziano Martello and colleagues uncover Tcfp2l1 as a critical downstream target of LIF/Stat3 signalling pathway in mouse ES cells. Here, the authors take advantage of Stat3-/-ES cells, which retain their self-renewal and pluripotent abilities if maintained in the presence of Mek and Gsk3 (2i) inhibitors. Other conditions (serum+LIF and PD+LIF) in contrast severely compromise Stat3-/-ES cell self-renewal, as the cells fail to respond to LIF signal transduction. Combining RNA-Seq analysis in LIF-stimulated Stat3+/+ and Stat3-/-ES cells and Stat3 ChiP-Seq dataset, they identify and validate Tcfp2l1 as a primary LIF/Stat3 target. Accordingly, Tcfp2l1 forced expression can substitute for LIF/Stat3 in Stat3-/-ES cells and furthermore supports an undifferentiated ES cell state in non-permissive conditions. Conversely, conditional loss of Tcfp2l1 is detrimental to ES cells unless grown in 2i+LIF conditions. Interrogation of Tcfp2l1 ChiP-Seq dataset indicates that Tcfp2l1 might partly act 'outside' the core transcriptional network to sustain ES cell self-renewal, with many Tcfp2l1-bound target genes being expressed in 2i+LIF conditions. Beyond its role in maintaining the ES cell identity, Tcfp2l1 is also revealed as a potent mediator of EpiS cell reprogramming to naïve pluripotency. Overall, I believe that this manuscript would be a nice candidate for EMBO and would be of interest to a broad readership in the fields of transcription, pluripotency and reprogramming.
Major concerns:
1-The study indicates that Tcfp2l1 potentially functions in parallel to the core transcriptional network to sustain ES cell self-renewal but falls short in explaining how Tcfp2l1 operates in this context. Figure 3F -G suggests that Tcfp2l1 plays a role in ES cell survival in addition to restraining differentiation. Could the authors clarify whether Tcfp2l1 conditional deletion indeed leads to an increased incidence of apoptosis (potentially rescued in the presence of caspase inhibitors) and whether "surviving" colonies retain a positive AP-staining? Important clues might also come from detailed gene ontology analysis of Tcfp2l1-bound targets ( Figure 5E ) with a specific focus on Tcfp2l1-bound genes that are expressed in 2i+LIF conditions as compared to serum + LIF (Marks et al. 2012 ).
We should clarify that the cell death we described following Tfcp2l1 knockdown in 2i is attributable to the culture conditions. The Mek inhibitor PD0325901 causes cell death in most differentiating cell types. We observe similar levels of cell death and differentiation when non-manipulated ES cells are exposed to PD alone in N2B27 media for more than 4 days. We repeated the experiments of Figure 3F- Figure S1D -E); • performed Gene Ontology analysis of Tfcp2l1 target genes in LIF+serum (see Figure S3A) . We found only 6 GO terms that barely reached statistical significance; they are related to glucose metabolism (Table below) . - Figure 1B and Figure 2D : please define RPKM in legend figure.
2-The authors report that Tcfp2l1 is homogeneously expressed in ES cells in contrast to
The Referee here suggests three alternative explanations for the spontaneous conversion to naïve pluripotency observed in GOF18 cells, namely: a) differences in the initial expression levels of Tfcp2l1at the population level; b) expression of Tfcp2l1in a subpopulation of GOF18 cells; c) differential expression of LIF/Stat3 pathway components.
We tested all 3 hypotheses: a) we directly compared the mRNA levels of Tfcp2l1 in GOF18 and O4GIP EpiSC cells in F/A and found no significant differences (Figure S2F). Of note, Tfcp2l1 expression in both EpiSC
Done
- Figure 3A: could the authors validate that all five PB-transgenes are expressed at similar levels (western blotting) prior to and after LIF removal? Figure S1B , the transgene expression levels are similar and range from 1.5 to 3 fold over the endogenous levels.
- Figure 3 : Data showing that Tcfp2l1-depleted ES cells are rescued in 2i + LIF need to be included in this manuscript.
Done, Figure S1D -E.
- Figure 4 : Different panels use 2i+LIF instead of PD +LIF as control conditions to be compared with PD alone. This needs to be changed or appropriately justified. Figure 4B ).
The main point of the western blot experiment was to show that Tfcp2l1 was expressed at nearly endogenous levels in PB-Tfcp2l1 cells. We reasoned that expression of Tfcp2l1 in LIF+PD would be lower than in 2i+LIF and therefore used PB-vector cells cultured in LIF+PD as a more stringent control. We acknowledge that this might generate confusion and therefore we repeated the Western blot using PB-Vector cells cultured in 2i+LIF and have replaced the panel (
We added the missing Legend axes. We generated a new panel where we directly compared the expression of Tfcp2l1 in O4GIP and GOF18 cells ( Figure S2F ). Moreover the "ES cell 2i+LIF" samples used in Figure 6C and S2B are identical, allowing direct comparison between the two experiments. This is now stated in the Figure legends.
- Figure 6K : please include ES cells 2i + LIF control as in Figure 6G and comment on any potential difference in the extent to which the expression of ES cell-associated factors is regained in O4GIP and GOF18 cells upon Tcfp2l1 forced expression. Figure 6G and S2D is the same, allowing direct comparison). Moreover, both lines showed an increased expression of Nanog and Tbx3, probably due to the increased expression of Tfcp2l1.
The ES cell 2i+LIF control has been included. We observe a marked increase in Tfcp2l1 levels in both iPS lines, probably due to the presence of the PB-transgene. The extent to which naïve pluripotency markers are regained in the two EpiSCs lines is comparable (the "ES cells 2i+LIF" control used in
The authors use a genome-wide approach and compared the transcriptiome of Stat3-null ESCs with available transcriptiome data to identify genes, whose expression could sustain self-renewal and pluripotency in the absence of LIF. They found a transcription factor, Tfcp2l1, which is necessary and sufficient to maintain pluripotency and self-renewal of ESCs and essential for the reprogramming of EpiSCs. The authors concluded Tfcp2l1 to be a major component of the LIF/Sat3 signalling pathway that is linked to the core transcription factors required for the maintenance of naive pluripotency. Overall the data are convincing and in accordance with the author's conclusions.
However, there are minor comments to be addressed. 1) It is surprising that the authors did not found NANOG in their screening. NANOG shown to support LIF-independent self-renewal of mouse ESCs (Niwa et al., 2009. Nature 460: 118-122) . Additionally, the authors have previously shown that the pluripotent factor Esrrb was also necessary and sufficient to sustain self-renewal and pluripotency of ESCs downstream Gsk3 inhibition (Martello et al., 2012. Cell Stem Cell 11: 491-504 Figure 4B and S1B). Most importantly, downregulation of Gbx2 did not compromise self-renewal (Figure 3D and Tai and Ying 2013) , whereas Tfcp2l1 knockdown resulted in ES cell differentiation. In addition, Gbx2 and Tfcp2l1 are both induced during EpiSC reprogramming triggered by LIF, but only Tfcp2l1 is required during the process ( Figure 6D ). We conclude that Gbx2 and Tfcp2l1 have partially redundant activities, but Tfcp2l1 is the main mediator of LIF/Stat3 activity To clarify these points we have introduced a summary schematic in Figure 6 3) Regarding Figure 4E , it would be best to include a graphical representation to better depict the result in the colony formation assay.
A graphical representation has been provided.
4)
The heatmap on Figure 6C shows the expression of Tfcp2l1 along with Gbx2 and Socs3 to be significantly increased after 48 hrs in 2i media under activated Stat3 conditions. Interestingly, the role of Socs3 was not evaluated by siRNA-targeting in the reprogramming assay on Figure 6D . Additionally, the effect of knocking down Pim1 does not seem to be statistically significantly different (by looking at the error bars) from the siRNA-mediated down regulation of Tfcp2l1. We now provide a schematic in Figure 6 illustrating 
Socs3 is a known direct target of the
